FIRST ON ZEE BUSINESS- Exports डिमांड थोड़ी कम, आगे सुधार की उम्मीद: अधीश पाटिल, CFO, आरती ड्रग्स

#newsparviews  #aartidrugsshare  #resultsonzee  #q2results #AnilSinghvi #zeebusiness  

#WhatsApp: http://bit.ly/3PK0ASF   

Zee Business LIVE: https://bit.ly/46zr7bt 




About Zee Business:

Zee Business is India's Number 1 Hindi business news channel. It's your channel for profit and wealth. Watch Live coverage of Indian markets - Sensex & Nifty, also for expert insights and advise from our team of experts.
 
--------------------------------------------------------------
Subscribe Zee Business: https://bit.ly/3L6GG0C
 
Business की हर बड़ी ख़बर से रहें अपडेट फॉलो करें ZEE Business का WhatsApp चैनल:   https://bit.ly/3RvzK1N

You Can Also Visit Our Website at: 

Zee Business: https://www.zeebiz.com/
Zee News: https://zeenews.india.com/
DNA India:-https://www.dnaindia.com/
WION: https://www.wionews.com/ 

Follow Us On: 
  
Facebook: https://goo.gl/OMJgrn
Twitter: https://goo.gl/OjOzpB 
Download Zee News App : https://bit.ly/ZeeNewsApps

Aarti Drugs: Export Challenges and Hope for Improvement, Mgmt. Insights With Anil Singhvi

Adani Ent. & Adani Wilmar to remain in focus as former explores selling stake. Singer India suspends BIS Certification Marks License. CCI approves HDFC Credila Financial Services’ acquisition. Netlink Solutions to open subsidiary in USA. Lupin’s US-based subsidiary gets US FDA approval. Capital Indi…

Focus on Adani Enterprises, Adani Wilmar, Singer India, CCI, Netlink Solutions, Lupin, Capital India Finance, Power Grid, Aarti Drugs, Zee Learn, Abbott India & More Ahead of Q2 Earnings on August 9

Axis Securities is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 665 in its research report dated July 25 2023.

Buy Aarti Drugs; target of Rs 665: Axis Securities

The company announced a buyback of 6,65,000 equity shares or 0.72% of its paid-up share capital, on July 21.

Aarti Drugs Buyback: All You Need To Know

Aarti Drugs’ buyback boosts share price 16.30%, to Rs.593.85.

Aarti Drugs shares surge over 16% on buyback approval

Q1 Hits & Misses | Aarti Drugs, AU Small Fin Bank, IGL & Titagarh Rail react to earnings. Ekta Batra, Sonal Bhutra & Reema Tendulkar get you the highlights. Listen in.

#Q1FY24earnings #Q1FY24earningshighlights #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettodaynews 


🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here

Aarti Drugs, CreditAccess Grameen Post Strong Results In Q1, Titagarh Rail Systems, IGL Disappoint

Deccan Gold Mines Ltd, Brightcom Group, Naukri Internet Services, SoftTech Engineers, Hikal Ltd, SJVN Ltd, Lupin, Power Finance Corp, Aurobindo Pharma, Biocon, Arunachal Pradesh, Aarti Drugs, Trident, GNA Axles, Jaykay Enterprises, Equipp Social Impact Tech & SenecaGlobal form JV, & Results Calendar…

Stocks that will see action: July 24, 2024

The company’s first-quarter net profit rose 37.14% YoY to Rs 48 crore. It also proposed to buyback 6.65 lakh shares.

Aarti Drugs Shares Surge Over 12% After Q1 Profit Jump, Proposes Share Buyback

The sharp reaction in Aarti Drugs was also fueled by strong volumes as they were significantly higher than the one-month daily traded average.

Aarti Drugs spikes 18% to hit 52-week high on buyback offer with sharp premium

Aarti Drugs Standalone June 2023 Net Sales at Rs 591.63 crore, up 7.33% Y-o-Y

Eicher Motors’ share price outlook is short-term negative, potentially declining to ₹3,020-3,000. Long-term investors can consider buying at ₹3,080 and ₹2,850 with a stop-loss at ₹2,650, targeting a rise towards ₹4,400. Consider exiting the range-bound stock of Deepak Nitrite at current levels due t…

Technical Analysis: Eicher Motors, Deepak Nitrite and Aarti Drugs

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is underpriced and is not in the overbought zone

Current price is less than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aarti Drugs Limited is a pharmaceutical company  offering active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins.

Aarti Drugs Ltd